437 related articles for article (PubMed ID: 25339261)
1. The new biology of estrogen-induced apoptosis applied to treat and prevent breast cancer.
Jordan VC
Endocr Relat Cancer; 2015 Feb; 22(1):R1-31. PubMed ID: 25339261
[TBL] [Abstract][Full Text] [Related]
2. Estrogen-mediated mechanisms to control the growth and apoptosis of breast cancer cells: a translational research success story.
McDaniel RE; Maximov PY; Jordan VC
Vitam Horm; 2013; 93():1-49. PubMed ID: 23810002
[TBL] [Abstract][Full Text] [Related]
3. The molecular, cellular and clinical consequences of targeting the estrogen receptor following estrogen deprivation therapy.
Fan P; Maximov PY; Curpan RF; Abderrahman B; Jordan VC
Mol Cell Endocrinol; 2015 Dec; 418 Pt 3(0 3):245-63. PubMed ID: 26052034
[TBL] [Abstract][Full Text] [Related]
4. The Structure-Function Relationship of Angular Estrogens and Estrogen Receptor Alpha to Initiate Estrogen-Induced Apoptosis in Breast Cancer Cells.
Maximov PY; Abderrahman B; Hawsawi YM; Chen Y; Foulds CE; Jain A; Malovannaya A; Fan P; Curpan RF; Han R; Fanning SW; Broom BM; Quintana Rincon DM; Greenland JA; Greene GL; Jordan VC
Mol Pharmacol; 2020 Jul; 98(1):24-37. PubMed ID: 32362585
[TBL] [Abstract][Full Text] [Related]
5. Selective estrogen-induced apoptosis in breast cancer.
Obiorah IE; Fan P; Sengupta S; Jordan VC
Steroids; 2014 Nov; 90():60-70. PubMed ID: 24929046
[TBL] [Abstract][Full Text] [Related]
6. Scientific rationale for postmenopause delay in the use of conjugated equine estrogens among postmenopausal women that causes reduction in breast cancer incidence and mortality.
Obiorah I; Jordan VC
Menopause; 2013 Apr; 20(4):372-82. PubMed ID: 23921472
[TBL] [Abstract][Full Text] [Related]
7. Sex steroid induced apoptosis as a rational strategy to treat anti-hormone resistant breast and prostate cancer.
Jordan VC; Fan P; Abderrahman B; Maximov PY; Hawsawi YM; Bhattacharya P; Pokharel N
Discov Med; 2016 May; 21(117):411-27. PubMed ID: 27355337
[TBL] [Abstract][Full Text] [Related]
8. Paradoxical clinical effect of estrogen on breast cancer risk: a "new" biology of estrogen-induced apoptosis.
Jordan VC; Ford LG
Cancer Prev Res (Phila); 2011 May; 4(5):633-7. PubMed ID: 21478501
[TBL] [Abstract][Full Text] [Related]
9. The apoptotic action of estrogen following exhaustive antihormonal therapy: a new clinical treatment strategy.
Jordan VC; Lewis JS; Osipo C; Cheng D
Breast; 2005 Dec; 14(6):624-30. PubMed ID: 16202599
[TBL] [Abstract][Full Text] [Related]
10. Endoxifen, 4-Hydroxytamoxifen and an Estrogenic Derivative Modulate Estrogen Receptor Complex Mediated Apoptosis in Breast Cancer.
Maximov PY; Abderrahman B; Fanning SW; Sengupta S; Fan P; Curpan RF; Rincon DMQ; Greenland JA; Rajan SS; Greene GL; Jordan VC
Mol Pharmacol; 2018 Aug; 94(2):812-822. PubMed ID: 29739819
[TBL] [Abstract][Full Text] [Related]
11. Low-dose estrogen therapy to reverse acquired antihormonal resistance in the treatment of breast cancer.
Swaby RF; Jordan VC
Clin Breast Cancer; 2008 Apr; 8(2):124-33. PubMed ID: 18621608
[TBL] [Abstract][Full Text] [Related]
12. Estrogen for the Treatment and Prevention of Breast Cancer: A Tale of 2 Karnofsky Lectures.
Abderrahman B; Jordan VC
Cancer J; 2022 May-Jun 01; 28(3):163-168. PubMed ID: 35594462
[TBL] [Abstract][Full Text] [Related]
13. The 38th David A. Karnofsky lecture: the paradoxical actions of estrogen in breast cancer--survival or death?
Jordan VC
J Clin Oncol; 2008 Jun; 26(18):3073-82. PubMed ID: 18519949
[TBL] [Abstract][Full Text] [Related]
14. Development and evolution of therapies targeted to the estrogen receptor for the treatment and prevention of breast cancer.
Jordan VC; Brodie AM
Steroids; 2007 Jan; 72(1):7-25. PubMed ID: 17169390
[TBL] [Abstract][Full Text] [Related]
15. Selective estrogen receptor modulators and the combination therapy conjugated estrogens/bazedoxifene: A review of effects on the breast.
Pickar JH; Komm BS
Post Reprod Health; 2015 Sep; 21(3):112-21. PubMed ID: 26289836
[TBL] [Abstract][Full Text] [Related]
16. Aromatase inhibitors: rationale for use following antiestrogen therapy.
Yue W; Santen RJ
Semin Oncol; 1996 Aug; 23(4 Suppl 9):21-7. PubMed ID: 8824461
[TBL] [Abstract][Full Text] [Related]
17. Basic guide to the mechanisms of antiestrogen action.
MacGregor JI; Jordan VC
Pharmacol Rev; 1998 Jun; 50(2):151-96. PubMed ID: 9647865
[TBL] [Abstract][Full Text] [Related]
18. The effect of second-line antiestrogen therapy on breast tumor growth after first-line treatment with the aromatase inhibitor letrozole: long-term studies using the intratumoral aromatase postmenopausal breast cancer model.
Long BJ; Jelovac D; Thiantanawat A; Brodie AM
Clin Cancer Res; 2002 Jul; 8(7):2378-88. PubMed ID: 12114443
[TBL] [Abstract][Full Text] [Related]
19. Rapid Induction of the Unfolded Protein Response and Apoptosis by Estrogen Mimic TTC-352 for the Treatment of Endocrine-Resistant Breast Cancer.
Abderrahman B; Maximov PY; Curpan RF; Fanning SW; Hanspal JS; Fan P; Foulds CE; Chen Y; Malovannaya A; Jain A; Xiong R; Greene GL; Tonetti DA; Thatcher GRJ; Jordan VC
Mol Cancer Ther; 2021 Jan; 20(1):11-25. PubMed ID: 33177154
[TBL] [Abstract][Full Text] [Related]
20. Molecular Action and Clinical Relevance of Aromatase Inhibitors.
Murphy MJ
Oncologist; 1998; 3(2):129-130. PubMed ID: 10388095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
